MaxCyte, Inc. Variable Lease, Cost
MaxCyte, Inc. (MXCT) reported Variable Lease, Cost of $393.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:VariableLeaseCost · last filed 2026-08-13
- MaxCyte, Inc. variable lease, cost for the quarter ending 2026-06-30 was $393.00K, a 27.60% increase year-over-year.
- MaxCyte, Inc. variable lease, cost for the quarter ending 2026-03-31 was $310.00K, a 8.77% increase year-over-year.
- MaxCyte, Inc. variable lease, cost for the quarter ending 2025-12-31 was $115.00K, a 53.33% increase year-over-year.
- MaxCyte, Inc. variable lease, cost for the quarter ending 2025-09-30 was $277.00K, a 7.36% decline year-over-year.
- MaxCyte, Inc. variable lease, cost for fiscal 2025 was $985.00K, a 1.55% increase from fiscal 2024.
- MaxCyte, Inc. variable lease, cost for fiscal 2024 was $970.00K, a 1.32% decline from fiscal 2023.
- MaxCyte, Inc. variable lease, cost for fiscal 2023 was $983.00K, a 85.47% increase from fiscal 2022.
- MaxCyte, Inc. variable lease, cost for fiscal 2022 was $530.00K, a 75.26% increase from fiscal 2021.
| Period end | Variable Lease, Cost 3 month | Variable Lease, Cost 3 month as first filed | Variable Lease, Cost 6 month | Variable Lease, Cost 6 month as first filed | Variable Lease, Cost 9 month | Variable Lease, Cost 9 month as first filed | Variable Lease, Cost 12 month | Variable Lease, Cost 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $393.00K 10-Q · filed 2026-08-13 | $703.00K 10-Q · filed 2026-08-13 | $818.00K derived: sum of 3 quarters · filed 2026-08-13 | $1.09M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2026-03-31 | $310.00K 10-Q · filed 2026-05-13 | $425.00K derived: sum of 2 quarters · filed 2026-05-13 | $702.00K derived: sum of 3 quarters · filed 2026-05-13 | $1.01M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-12-31 | $115.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $392.00K derived: sum of 2 quarters · filed 2026-03-25 | $700.00K derived: sum of 3 quarters · filed 2026-08-13 | $985.00K 10-K · filed 2026-03-25 | ||||
| 2025-09-30 | $277.00K 10-Q · filed 2025-11-13 | $585.00K derived: sum of 2 quarters · filed 2026-08-13 | $870.00K 10-Q · filed 2025-11-13 | $945.00K derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-06-30 | $308.00K 10-Q · filed 2026-08-13 | $593.00K 10-Q · filed 2026-08-13 | $668.00K derived: sum of 3 quarters · filed 2026-08-13 | $967.00K derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-03-31 | $285.00K 10-Q · filed 2026-05-13 | $360.00K derived: sum of 2 quarters · filed 2026-05-13 | $659.00K derived: sum of 3 quarters · filed 2026-05-13 | $957.00K derived: sum of 4 quarters · filed 2026-05-13 | ||||
| 2024-12-31 | $75.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $374.00K derived: sum of 2 quarters · filed 2026-03-25 | $672.00K derived: sum of 3 quarters · filed 2026-03-25 | $970.00K 10-K · filed 2026-03-25 | ||||
| 2024-09-30 | $299.00K 10-Q · filed 2025-11-13 | $597.00K derived: sum of 2 quarters · filed 2025-11-13 | $895.00K 10-Q · filed 2025-11-13 | $1.16M derived: sum of 4 quarters · filed 2025-11-13 | ||||
| 2024-06-30 | $298.00K 10-Q · filed 2025-08-06 | $596.00K 10-Q · filed 2025-08-06 | $864.00K derived: sum of 3 quarters · filed 2025-08-06 | $1.18M derived: sum of 4 quarters · filed 2025-08-06 | ||||
| 2024-03-31 | $298.00K 10-Q · filed 2025-05-08 | $566.00K derived: sum of 2 quarters · filed 2025-05-08 | $879.00K derived: sum of 3 quarters · filed 2025-05-08 | $1.11M derived: sum of 4 quarters · filed 2025-05-08 | ||||
| 2023-12-31 | $268.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-11 | $581.00K derived: sum of 2 quarters · filed 2025-03-11 | $817.00K derived: sum of 3 quarters · filed 2025-03-11 | $983.00K 10-K · filed 2025-03-11 | ||||
| 2023-09-30 | $313.00K 10-Q · filed 2024-11-06 | $313.40K 10-Q · filed 2023-11-08 | $549.00K derived: sum of 2 quarters · filed 2024-11-06 | $715.00K 10-Q · filed 2024-11-06 | $714.70K 10-Q · filed 2023-11-08 | $887.50K derived: sum of 4 quarters · filed 2024-11-06 | ||
| 2023-06-30 | $236.00K 10-Q · filed 2024-08-06 | $236.10K 10-Q · filed 2023-08-09 | $401.00K 10-Q · filed 2024-08-06 | $401.30K 10-Q · filed 2023-08-09 | $574.50K derived: sum of 3 quarters · filed 2024-08-06 | $716.00K derived: sum of 4 quarters · filed 2024-08-06 | ||
| 2023-03-31 | $165.00K 10-Q · filed 2024-05-07 | $165.20K 10-Q · filed 2023-05-10 | $338.50K derived: sum of 2 quarters · filed 2024-05-07 | $480.00K derived: sum of 3 quarters · filed 2024-05-07 | $619.60K derived: sum of 4 quarters · filed 2024-05-07 | |||
| 2022-12-31 | $173.50K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-12 | $315.00K derived: sum of 2 quarters · filed 2024-03-12 | $454.60K derived: sum of 3 quarters · filed 2024-03-12 | $530.00K 10-K · filed 2024-03-12 | $530.20K 10-K · filed 2023-03-15 | |||
| 2022-09-30 | $141.50K 10-Q · filed 2023-11-08 | $281.10K derived: sum of 2 quarters · filed 2023-11-08 | $356.50K 10-Q · filed 2023-11-08 | $432.10K derived: sum of 4 quarters · filed 2023-11-08 | ||||
| 2022-06-30 | $139.60K 10-Q · filed 2023-08-09 | $215.00K 10-Q · filed 2023-08-09 | $290.60K derived: sum of 3 quarters · filed 2023-08-09 | $366.20K derived: sum of 4 quarters · filed 2023-08-09 | ||||
| 2022-03-31 | $75.40K 10-Q · filed 2023-05-10 | $151.00K derived: sum of 2 quarters · filed 2023-05-10 | $226.60K derived: sum of 3 quarters · filed 2023-05-10 | $302.20K derived: sum of 4 quarters · filed 2023-05-10 | ||||
| 2021-12-31 | $75.60K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-15 | $151.20K derived: sum of 2 quarters · filed 2023-03-15 | $226.80K derived: sum of 3 quarters · filed 2023-03-15 | $302.40K 10-K · filed 2023-03-15 | ||||
| 2021-09-30 | $75.60K 10-Q · filed 2022-11-09 | $151.20K derived: sum of 2 quarters · filed 2022-11-09 | $226.80K 10-Q · filed 2022-11-09 | $300.80K derived: sum of 4 quarters · filed 2022-11-09 | ||||
| 2021-06-30 | $75.60K 10-Q · filed 2022-08-10 | $151.20K 10-Q · filed 2022-08-10 | $225.20K derived: sum of 3 quarters · filed 2022-08-10 | $299.20K derived: sum of 4 quarters · filed 2022-08-10 | ||||
| 2021-03-31 | $75.60K 10-Q · filed 2022-05-09 | $149.60K derived: sum of 2 quarters · filed 2022-05-09 | $223.60K derived: sum of 3 quarters · filed 2022-05-09 | $289.30K derived: sum of 4 quarters · filed 2022-05-09 | ||||
| 2020-12-31 | $74.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-22 | $148.00K derived: sum of 2 quarters · filed 2022-03-22 | $213.70K derived: sum of 3 quarters · filed 2022-03-22 | $289.50K 10-K · filed 2022-03-22 | ||||
| 2020-09-30 | $74.00K 10-Q · filed 2021-11-10 | $139.70K derived: sum of 2 quarters · filed 2021-11-10 | $215.50K 10-Q · filed 2021-11-10 | |||||
| 2020-06-30 | $65.70K 10-Q · filed 2021-09-13 | $141.50K 10-Q · filed 2021-09-13 | ||||||
| 2019-12-31 | $217.70K 10-K · filed 2022-03-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |